Almirall Hermal GmbH
Industry / private company
Location:
Reinbek,
Germany (DE)
ISNI: 0000000405516030
ROR: https://ror.org/04v3pva14
Show on Map:
CHALLENGES OF NETWORK META-ANALYSIS FOR SAFETY OUTCOMES: THE ANALYSIS OF TIRBANIBULIN AGAINST COMMON TREATMENTS IN EUROPE FOR ACTINIC KERATOSIS (2022)
Heppt M, Dykukha I, Chapman-Rounds M, Graziadio S, Edwards M
Conference contribution
ASSESSING SIMILARITY OF STUDIES FOR NETWORK META-ANALYSIS: THE USE OF FEASIBILITY ASSESSMENT AND SENSITIVITY ANALYSES TO ESTIMATE THE EFFICACY OF TIRBANIBULIN, A NEW DRUG FOR ACTINIC KERATOSIS (2022)
Heppt M, Dykukha , Chapman-Rounds M, Graziadio S, Edwards M
Conference contribution
Comparative Efficacy and Safety of Tirbanibulin for Actinic Keratosis of the Face and Scalp in Europe: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials (2022)
Heppt M, Dykukha I, Graziadio S, Salido-Vallejo R, Chapman-Rounds M, Edwards M
Journal article, Review article
A novel antiproliferative, pro-apoptotic Approach for the Treatment of actinic Keratoses: Tirbanibulin (KX2-391) (2021)
Heppt M, Ocker WG, Melzer A
Conference contribution